• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Pergolide-[d7]

General Information
Catalog: BLP-015235
CAS: 3026226-89-8
Molecular Formula: C19H19D7N2S
Molecular Weight: 321.53
Chemical Structure
Pergolide-[d7]
Description Pergolide-[d7] is the labelled analogue of Pergolide. Pergolide is an ergoline-based dopamine receptor agonist used in some countries for the treatment of Parkinson's disease.
Synonyms Pergolide-d7; (6aR,9R,10aR)-9-((Methylthio)methyl)-7-(propyl-d7)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
IUPAC Name (6aR,9R,10aR)-7-(1,1,2,2,3,3,3-heptadeuteriopropyl)-9-(methylsulfanylmethyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline
Related CAS 66104-22-1 (unlabelled) 3026226-90-1 (mesylate salt)
Canonical SMILES [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])N1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC
InChI InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1/i1D3,3D2,7D2
InChI Key YEHCICAEULNIGD-GBRFRXTQSA-N

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x